Other OTC - Delayed Quote USD

Premier Biomedical, Inc. (BIEI)

0.0013 -0.0001 (-7.14%)
At close: 3:34 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
Total Revenue
14.2810
Cost of Revenue
12.8600
Gross Profit
1.4210
Operating Expense
328.1560
Operating Income
-326.7350
Net Non Operating Interest Income Expense
-392.5490
Other Income Expense
344.8140
Pretax Income
-374.4700
Net Income Common Stockholders
-374.4700
Diluted NI Available to Com Stockholders
-374.4700
Basic EPS
-0.01
Diluted EPS
-0.01
Basic Average Shares
52,402.9120
Diluted Average Shares
52,402.9120
Total Operating Income as Reported
-326.7350
Total Expenses
341.0160
Net Income from Continuing & Discontinued Operation
-374.4700
Normalized Income
-719.2840
Interest Expense
392.5490
Net Interest Income
-392.5490
EBIT
18.0790
EBITDA
20.9090
Reconciled Cost of Revenue
12.8600
Reconciled Depreciation
2.8300
Net Income from Continuing Operation Net Minority Interest
-374.4700
Total Unusual Items Excluding Goodwill
344.8140
Total Unusual Items
344.8140
Normalized EBITDA
-323.9050
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GRPS Gold River Productions, Inc.
0.0037
-6.09%
 
IGPK Integrated Cannabis Solutions, Inc.
0.0156
+0.65%
 
ELTP Elite Pharmaceuticals, Inc.
0.1295
+2.53%
 
AKAN Akanda Corp.
0.0915
+2.01%
 
SXTC China SXT Pharmaceuticals, Inc.
1.0300
-3.74%